These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9053533)

  • 1. [Clinical studies on vancomycin in the treatment of MRSA infection].
    Shimizu K; Orizu M; Kanno H; Kitamura S; Konishi T; Soma K; Nishitani H; Noguchi Y; Hasegawa S; Hasegawa H; Wada K
    Jpn J Antibiot; 1996 Aug; 49(8):782-99. PubMed ID: 9053533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent findings based on the results of the post-marketing surveillance of vancomycin hydrochloride for intravenous infusion].
    Shimada K
    Jpn J Antibiot; 2003 Aug; 56(4):259-71. PubMed ID: 14567250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
    Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
    J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
    Hatano K; Yokota Y; Hanaki H; Sunakawa K
    Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
    Ishii T; Takayama Y; Takase Y; Orikasa Y
    Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
    Otsuka M; Sawahata T; Nakai T; Hasegawa S; Iwata S; Yoshizawa Y; Ishida H; Irokawa M; Goto A; Shinohara Y
    Jpn J Antibiot; 1994 Jun; 47(6):781-9. PubMed ID: 8072187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of arbekacin on MRSA infections].
    Ichiyama S; Shimokata K
    Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin.
    Oshiro T; Nagasawa Z; Hanaki H; Ikeda-Dantsuji Y; Nagayama A
    J Infect Chemother; 2008 Feb; 14(1):15-22. PubMed ID: 18297444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
    Sato S; Miura T; Kudo Y; Kudo E; Saitoh Y; Kimpara I; Tsujino M; Kudo H
    Jpn J Antibiot; 1998 Jul; 51(7):488-93. PubMed ID: 9755432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective single and combined chemotherapeutic regimens as regards to antibiotic resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) in Japan].
    Watanabe A
    Nihon Rinsho; 1992 May; 50(5):1060-5. PubMed ID: 1507429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M
    J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
    Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on MRSA infections and replacement of bacteria. Efficacy of vancomycin-ceftazidime combination therapy].
    Matsuoka K; Nagatomi Y; Imanishi K; Matsubara M; Nakanishi I; Watanabe H
    Jpn J Antibiot; 1994 Oct; 47(10):1363-8. PubMed ID: 7807696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice.
    Kaneko Y; Yanagihara K; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Tashiro T; Murata I; Kohno S
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3694-8. PubMed ID: 14638467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
    Sato S; Miura T; Kudo E; Kudo Y; Saitoh Y; Kimpara I; Tsujino M; Kudo H
    Jpn J Antibiot; 1997 Aug; 50(8):711-6. PubMed ID: 9339397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.